Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?

被引：0
|
作者：
Borriello, G. [1 ]
Prosperini, L. [1 ]
Mancinelli, C. [1 ]
Fubelli, F. [1 ]
Gianni, C. [1 ]
Marinelli, F. [1 ]
Pozzilli, C. [1 ]
机构：
[1] S Andrea Hosp, Rome, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P529
引用
下载
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [21] Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia
    La Mantia, Loredana
    Prone, Valentina
    Marazzi, Maria Raffaella
    Erminio, Cristina
    Protti, Alessandra
    NEUROLOGICAL SCIENCES, 2014, 35 (09) : 1485 - 1486
  • [22] Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia
    Loredana La Mantia
    Valentina Prone
    Maria Raffaella Marazzi
    Cristina Erminio
    Alessandra Protti
    Neurological Sciences, 2014, 35 : 1485 - 1486
  • [23] Catastrophic rebound after natalizumab treatment discontinuation
    Gonzalez Suarez, I.
    Orviz, A.
    Matias-Guiu, J.
    Valencia, C.
    Moreno-Garcia, S.
    Valle-Arcos, M. D.
    Rodriguez de Antonio, L.
    Jorquera-Moya, M.
    Oreja-Guevara, C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S304 - S304
  • [24] Catastrophic rebound after natalizumab treatment discontinuation
    Gonzalez Suarez, I.
    Orviz, A.
    Matias-Guiu, J.
    Valencia, C.
    Moreno-Garcia, S.
    Valle-Arcos, M. D.
    Rodriguez de Antonio, L.
    Jorquera-Moya, M.
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 458 - 458
  • [25] Disease activity return after natalizumab cessation in multiple sclerosis
    Rasenack, Maria
    Derfuss, Tobias
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 587 - 594
  • [26] Rebound Disease Activity Reduction in Relapsing Multiple Sclerosis Patients Transitioned From Natalizumab to Teriflunomide
    Cohan, Stanley
    Edwards, Keith R.
    Chen, Chiayi
    Gervasi, Tiffany
    O'Connor, Judy
    Smoot, Kyle
    Kresa-Reahl, Kiren
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 70 - 70
  • [27] Rebound disease activity reduction in relapsing multiple sclerosis patients transitioned from natalizumab to teriflunomide
    Cohan, S.
    Edwards, K.
    Chen, C.
    Gervasi, T.
    O'Connor, J.
    Smoot, K.
    Kresa-Reahl, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 313 - 313
  • [28] Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab
    Verhaeghe, Alexander
    Deryck, Olivier Maurice
    Vanopdenbosch, Ludo J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 279 - 281
  • [29] Fingolimod reduces the risk of recurrence of disease activity during the first 12 months after natalizumab discontinuation in multiple sclerosis
    Havla, J.
    Tackenberg, B.
    Hellwig, K.
    Meinl, I.
    Krumbholz, M.
    Seitz, F.
    Eienbroecker, C.
    Gold, R.
    Hohlfeld, R.
    Kleiter, I.
    Kuempfel, T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 230 - 231
  • [30] Analysis of disease activity return after natalizumab withdrawal in multiple sclerosis
    Fuentes Rumi, Luna
    Cabrera Maqueda, Jose Maria
    Carreon Guarnizo, Ester
    Hernandez Clares, Rocio
    Alba Isasi, Maria Teresa
    Vazquez Lorenzo, Julian
    Vazquez Lorenzo, Gabriel
    Baidez Guerrero, Ana Ester
    Morales de la Prida, Moises
    Canovas Iniesta, Maria
    Jimenez Veiga, Judith
    Leon Hernandez, Adelaida
    Velazquez Marin, Francisca
    Zamarro Parra, Joaquin
    Iniesta Martinez, Francisca
    Morales Ortiz, Ana
    Meca Lallana, Jose
    NEUROLOGY, 2019, 92 (15)
12345